Abciximab did not reduce death or myocardial infarction in the acute coronary syndrome without early revascularization

Borzak, Steven
March 2002
ACP Journal Club;Mar/Apr2002, Vol. 136 Issue 2, p44
Academic Journal
Presents information on a study which examined the effectiveness of abciximab in reducing mortality or myocardial infarction among patients with acute coronary syndrome. Methodology of the study; Results; Comments on the outcome of the study.


Related Articles

  • Estimation of high sensitivity C-reactive protein in patients with periodontal disease and without coronary artery disease. Anitha, V.; Nair, Sushma; Shivakumar, V.; Shanmugam, M.; Priya, B. Meena; Rajesh, P. // Indian Journal of Dental Research;Sep/Oct2015, Vol. 26 Issue 5, p500 

    Background: HsCRP (Highly sensitive C reactive protein) is a global indicator for future vascular events in adults detected in blood stream 48 hours before the cardiovascular event. Periodontal disease may increase blood levels of inflammatory markers like IL-6, CRP and HsCRP. Hence...

  • Sprint study: Aim for lower blood-pressure target to save lives. TALSMA, JULIA // Drug Topics;Dec2015, Vol. 159 Issue 12, p47 

    The article offers information on Systolic Blood Pressure Intervention Trial (SPRINT) study that enrolled more than 9,300 individuals older than 50 years of age and had a history of any risk factor for heart disease, reveals these patients has less likely to have heart attack.

  • Extended Use Could Prove Risky.  // USA Today Magazine;Oct2015 Newsletter Edition, Vol. 144 Issue 2845, p11 

    The article discusses the need for critical review of guidelines related to the use of statin drugs issued by the American Heart Association, Dallas, Texas, and the American College of Cardiology, Washington, D.C. It notes a statement by the Association of American Physicians and Surgeons that...

  • Association between CHADS2 Score and the Preventive Effect of Statin Therapy on New-Onset Atrial Fibrillation in Patients with Acute Myocardial Infarction. Huang, Shao-Sung; Chan, Wan-Leong; Leu, Hsin-Bang; Huang, Po-Hsun; Chen, Jaw-Wen; Lin, Shing-Jong // PLoS ONE;Aug2013, Vol. 8 Issue 8, p1 

    Objectives:New-onset atrial fibrillation (AF) commonly occurs in patients with acute myocardial infarction (AMI). Data regarding the value of the CHADS2 score in patients hospitalized for AMI is limited. This study aimed to determine whether the CHADS2 score is associated with new-onset AF and...

  • Aldosterone Inhibition and Cardiovascular Protection: More Important Than it Once Appeared. Martinez, Felipe A. // Cardiovascular Drugs & Therapy;Aug2010, Vol. 24 Issue 4, p345 

    ldosterone is present and active all along the cardiovascular continuum. Excessive tissue production occurs in cardiovascular diseases including myocardial infarction (MI) and heart failure, resulting in a multitude of adverse effects in the cardiovascular system necessitating pharmacologic...

  • Statins Sustain Cardiac Victims.  // USA Today Magazine;Feb2005, Vol. 133 Issue 2717, p9 

    Reports on the results of a study conducted by researchers at the University of Texas Southwestern Medical Center in Dallas which deals with the use of cholesterol-lowering medicines in heart attack patients. Benefits of the cholesterol-lowering drugs for heart attack patients; Effect of statin...

  • Nearer is Better. van Vlaanderen, Edward // Cortlandt Forum;05/25/2000, Vol. 13 Issue 5, p135 

    Examines the difference in the treatment and outcomes of myocardial infarction (MI) in hospitals with and without invasive capability in the United States. Estimate on the number of Americans suffering from heart diseases; Advantages of taking the ambulance for patients suffering from chest...

  • Direct transportation, cath lab notification after STEMI tripled number of patients treated within guideline timeframe.  // Cardiology Today;Sep2010, Vol. 13 Issue 9, p38 

    The article focuses on a 2010 study which deals with the increase in patient population treated within the time window of the guidelines as a result of direct transportation and catheterization (cath) laboratory notification following ST-segment myocardial infarction (STEMI).

  • Tenecteplase plus enoxaparin or abciximab was better than tenecteplase plus unfractionated heparin for acute MI.  // ACP Journal Club;Mar/Apr2002, Vol. 136 Issue 2, p43 

    Presents information on a study which compared the effectiveness and safety of tenecteplase (TNK) plus enoxaparin with TNK plus enoxaparin in patients with acute myocardial infarction. Methodology of the study; Results; Conclusion.

  • Statin Drugs Lower Artery Plaque.  // Clarendon Enterprise (TX);2/22/2007, Vol. 18 Issue 10, p8 

    The article reports the findings of a study which showed that the effect of a statin is expected to lower the risk of a heart attack or stroke.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics